Intelligence Profile
Safety Profile
Evidence Limitations: The available evidence provides very limited specific safety data for astaxanthin supplementation. Most of the provided studies focus on mechanisms of action, formulation development, or efficacy rather than detailed safety profiles. Safety information must be considered preliminary given the thin evidence base.
Known Side Effects:
Direct safety data from the provided evidence is extremely limited. One clinical trial (NCT03807050) specifically examined "Safety and Pharmacokinetics of Phaffia Rhodozyma Astaxanthin" and has been completed, but detailed results are not provided in the available evidence. Without access to the actual safety outcomes from this and other completed trials, specific side effect profiles cannot be definitively established from the current evidence.
Contraindications:
No specific contraindications are identified in the provided evidence. This represents a significant gap in available safety information.
Drug Interactions:
The provided evidence does not contain information about drug interactions with astaxanthin. This is a notable limitation, as potential interactions with medications should be considered before supplementation.
Special Populations:
The evidence does not provide specific guidance for pregnant women, nursing mothers, children, elderly individuals, or those with underlying medical conditions. One study mentions use in taekwondo athletes over 28 days, suggesting some evaluation in healthy active adults, but broader population safety data is not available.
Dosing and Duration Considerations:
One study references "28-day astaxanthin supplementation" in athletes, suggesting short-term use has been evaluated, but optimal dosing and long-term safety parameters are not established in the provided evidence.
Important Safety Note: Given the limited safety data in the provided evidence, individuals should consult with healthcare professionals before beginning astaxanthin supplementation, particularly if taking medications or having underlying health conditions. The absence of reported adverse events in the available studies should not be interpreted as proof of safety without more comprehensive safety data.
Disclaimer: This information is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any new supplement regimen.